Evidence map›Paper›PMID 36779708›Full record

ArticlemBio2023

Mutations in

Yesha Patel, Vijay Soni, Kyu Y Rhee, John D Helmann

Open access · goldAbstract read
In one paragraph

Article in mBio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Microbiology (Reading, England) · 2026
    Article
  8. Article
  9. Methicillin-resistantAntimicrobial agents and chemotherapy · 2026
    Article
  10. bioRxiv : the preprint server for biology · 2026
    Article
  11. HflX mediates rifampicin resistance inFrontiers in microbiology · 2026
    Article
  12. Functional Characterization ofAntibiotics (Basel, Switzerland) · 2026
    Article
  13. Article
  14. ThebioRxiv : the preprint server for biology · 2025
    Article
  15. Article
  16. Article
  17. Antibiotic resistome in the glacier forelands of polar regions.Applied and environmental microbiology · 2025
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yesha PatelDepartment of Microbiology, Cornell University, Ithaca, New York, USA.ORCID 0000-0001-9888-9888
Vijay SoniDepartment of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, USA.ORCID 0000-0002-3395-7429
Kyu Y RheeDepartment of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, USA.ORCID 0000-0003-4582-2895
John D HelmannDepartment of Microbiology, Cornell University, Ithaca, New York, USA.ORCID 0000-0002-3832-3249
Cornell University · US

Funding

Study of M. tuberculosis under human host selection to identify virulence and barrier lipids (Project 1)U19AI162584 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI WOOD, ROBIN · 2021 to 2025
$13.5M
Bacillus subtilis Stress ResponsesR35GM122461 · NIGMS · CORNELL UNIVERSITY · PI John D Helmann · 2017 to 2026
$7.6M
NIAID NIH HHS U19 AI162584NIGMS NIH HHS R35 GM122461
6 · The paper itself

Abstract

Bacteria can adapt to stressful conditions through mutations affecting the RNA polymerase core subunits that lead to beneficial changes in transcription. In response to selection with rifampicin (RIF), mutations arise in the RIF resistance-determining region (RRDR) of

Indexed as

Mycobacterium tuberculosisRifampinAcetylglucosamineAntitubercular AgentsBacterial Proteinsbeta-LactamsCefuroximeDNA-Directed RNA PolymerasesDrug Resistance, BacterialMicrobial Sensitivity TestsMutationPeptidoglycanUridine DiphosphateAcetylglucosamineAntitubercular AgentsBacterial Proteinsbeta-LactamsCefuroximeDNA-Directed RNA PolymerasesPeptidoglycanRifampinUridine Diphosphateantibiotic resistanceantibiotic synergyBacillus subtilismetabolomicsMycobacterium tuberculosispeptidoglycanrifampicinRNA polymerasesβ-lactams

Identifiers

PMID36779708
PMCPMC10128067
OpenAlexW4320485716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.